Kenneth L
Custer,
President and General Manager
(Corporation)
Learn more...
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
-
Eli Lilly Canada Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Judith Seidman,
Senator
|
Senate of Canada
Subject Matter of the communication:
Health
Communication date:
2024-06-27
Posted date:
2024-07-15
Communication number:
6034-609625
View associated registration
-
Eli Lilly Canada Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Bobby Chauhan,
Director
|
Health Canada (HC)
-
Daniel MacDonald,
Director General, Drugs for Rare Diseases
| Strategic Policy Branch
|
Health Canada (HC)
-
Michelle Boudreau,
Executive Director
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2024-06-06
Posted date:
2024-07-15
Communication number:
6034-609621
View associated registration
-
Eli Lilly Canada Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Paul Brogan,
Market Director
|
Invest in Canada Hub
-
Harold Dremin,
Chief Investor Services Officer
|
Invest in Canada Hub
Subject Matter of the communication:
Health,
Industry
Communication date:
2024-06-04
Posted date:
2024-07-04
Communication number:
6034-609623
(amended from
6034-609622)
View associated registration
-
Eli Lilly Canada Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health
Communication date:
2024-06-02
Posted date:
2024-07-15
Communication number:
6034-609619
View associated registration
-
Eli Lilly Canada Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
-
Laura Stokes,
Policy Analyst
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health
Communication date:
2024-05-24
Posted date:
2024-06-15
Communication number:
6034-606160
View associated registration
-
Eli Lilly Canada Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jade Mallette,
Director of Parliamentary Affairs
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2024-05-21
Posted date:
2024-06-15
Communication number:
6034-605252
View associated registration
-
Eli Lilly Canada Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Connor MacDonald,
Policy Advisor
|
House of Commons
-
Bryce McRae,
Manager of Stakeholder Relations
| Conservative - House Officers
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2024-05-21
Posted date:
2024-06-15
Communication number:
6034-605251
View associated registration
-
Eli Lilly Canada Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Yash Nanda,
Policy Advisor
|
Finance Canada (FIN)
Subject Matter of the communication:
Health
Communication date:
2024-04-22
Posted date:
2024-05-15
Communication number:
6034-603127
View associated registration
-
Eli Lilly Canada Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Michelle Ciesielski,
Manager, Office of Patented Medicines and Liaison
|
Health Canada (HC)
-
Anne Bowes,
Director
|
Health Canada (HC)
-
David Lee,
Chief Regulatory Officer
|
Health Canada (HC)
-
Erin Campbell,
Director
|
Innovation, Science and Economic Development Canada (ISED)
-
Paul Brogan,
Market Director
|
Invest in Canada Hub
Subject Matter of the communication:
Health
Communication date:
2024-02-26
Posted date:
2024-03-15
Communication number:
6034-595827
View associated registration
-
Eli Lilly Canada Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Loris Mirella,
Director
|
Global Affairs Canada (GAC)
-
David Norris,
Senior Trade Policy Officer
|
Global Affairs Canada (GAC)
Subject Matter of the communication:
Health
Communication date:
2024-01-31
Posted date:
2024-02-15
Communication number:
6034-592233
View associated registration
-
Eli Lilly Canada Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ritu Banerjee,
Assistant Deputy Minister
| Director General's Office
|
Innovation, Science and Economic Development Canada (ISED)
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
-
Caroline Menard,
Manager
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
-
Benoit Leduc,
Manager
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health
Communication date:
2024-01-23
Posted date:
2024-02-15
Communication number:
6034-592232
View associated registration
-
Eli Lilly Canada Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Yash Nanda,
Policy Advisor
|
Finance Canada (FIN)
Subject Matter of the communication:
Health
Communication date:
2024-01-23
Posted date:
2024-02-15
Communication number:
6034-592230
View associated registration
-
Eli Lilly Canada Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Eshan Naik,
Director of Policy
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2024-01-23
Posted date:
2024-02-15
Communication number:
6034-592192
View associated registration